There are 3163 resources available
How do we manage patient progression?
Presenter: Fiona Thistlethwaite
Session: Which patients should we treat beyond progression and when should we stop?
Resources:
Slides
Webcast
Liquid profiling of molecular metastatic disease and impact on decision making
Presenter: Noelia Tarazona Llavero
Session: New technology, new ideas: What is on the horizon for colorectal cancer?
Resources:
Slides
Webcast
Patients with bone metastases
Presenter: Robbe Van Den Begin
Session: Management of oligoprogressive disease
Resources:
Slides
Webcast
Invited Discussant 1241MO, 1206MO and 1207MO
Presenter: Heather Wakelee
Session: Mini oral session 2: Non-metastatic NSCLC
Resources:
Slides
Webcast
Q&A
Session: Proffered paper session: NETs and endocrine tumours
Resources:
Webcast
Future directions in the development and use of Real World Evidence
Presenter: Miriam Koopman
Session: How Real World Data (RWD) are transforming oncology
Resources:
Slides
Webcast
Expanding proteome interrogation to identify early phase clinical trial biomarkers
Presenter: Janne Lehtiö
Session: The evolving diagnostic landscape of early phase trials
Resources:
Slides
Webcast
Q&A and discussion
Session: Treatment of difficult lymphomas
Resources:
Webcast
What about long-term toxicities?
Presenter: Eleonora Ghisoni
Session: Improving the management of toxicities from immunotherapy
Resources:
Slides
Webcast
Discussion
Session: How can we best manage locally-advanced and persistent cervical cancers?
Resources:
Webcast